Searchable abstracts of presentations at key conferences in endocrinology

ea0010p58 | Pituitary | SFE2005

Pituitary tumour, yes or no? – A DGH experience

Narasimhan S , Babu S , Ramasamy S , Scobie I , Gough A

Introduction: Diseases of the hypothalamus/pituitary are complex and can be difficult to diagnose. Diagnostic possibilities are many and include sphenoid ridge meningiomas and aneurysms of the internal carotid artery as well as craniopharyngiomas, gliomas of the optic nerve, inflammatory and granulomatous disease.Case report: We present two cases to illustrate the complex differential diagnosis.The first patient presented with head...

ea0010p91 | Thyroid | SFE2005

Lack of association of interleukin-13 polymorphisms with Graves’ disease

Heward J , Simmonds M , Franklyn J , Gough S

Genome wide screens in Graves’ disease (GD) have identified several regions of linkage which may harbour genes which contribute to disease susceptibility. One such region, on chromosome 5q31-33, contains a cytokine cluster which includes interleukin-13 (IL-13). This molecule plays a key role in IgE production, which has been reported to be elevated in patients with GD. Two functional single nucleotide polymorphisms (SNPs), -1112 and +2044, within the IL-13 gene were recen...

ea0007oc22 | Thyroid | BES2004

Defining genetic predictors for the development of Graves' disease in young females

Collins J , Heward J , Cordell H , Franklyn J , Gough S

The HLA and CTLA-4 gene regions, on chromosomes 6p21 and 2q33 respectively, have been consistently associated with Graves' disease (GD). Recent data indicate that both DRB1 (in the HLA class II region) and the 3' untranslated region of the CTLA-4 gene are the most likely regions harbouring the aetiological variants for susceptibility to GD. It is not known, however, whether these variants lead to expression of specific sub-phenotypes in subjects with GD, or contribute to disea...

ea0007p227 | Thyroid | BES2004

No association of a polymorphism in the kozak sequence of the CD40 gene and Graves' disease in a UK Caucasian population

Foxall H , Heward J , Franklyn J , Gough S

Graves' disease (GD) is an autoimmune disease of the thyroid gland with unknown aetiology thought to be caused by a complex interaction between genetic and environmental factors. To date, the HLA region on chromosome 6p21 and the CTLA-4 gene on chromosome 2q33 are thought to account for about 50% of the genetic component of GD with the remaining genetic contribution likely to be made up of many genes each exerting a small effect on predisposition to disease. A recent study (To...

ea0005p264 | Thyroid | BES2003

Is the thyroglobulin gene a susceptibility locus for autoimmune thyroid disease in the UK?

Collins J , Heward J , Franklyn J , Gough S

The autoimmune thyroid diseases (AITDs), Graves' disease (GD) and Hashimoto's thyroiditis (HT), are thought to be caused by complex interactions between genetic and environmental factors, which result in an organ-specific autoimmune response being directed against the thyroid gland. GD and HT, although clinically distinct, share many immunological and histological features. Several potential susceptibility genes for AITD have been investigated, although to date only the HLA an...

ea0005p265 | Thyroid | BES2003

Assessment of UK caucasian allele frequencies of known TNF-alpha polymorphisms and their association with Graves' disease

Simmonds M , Nithiyananthan R , Heward J , Franklyn J , Gough S

Tumour necrosis factor-alpha (TNF-alpha) plays an important role in the initiation and regulation of the cytokine cascade during an inflammatory response and is, therefore, a good candidate for involvement in the development of autoimmune disease. The TNF-alpha gene has been mapped to chromosome 6p21.3 and many single nucleotide polymorphisms (SNPs) have been detected within the gene that could affect its function. The allele frequencies of these SNPs and their relationship to...

ea0021p48 | Clinical practice/governance and case reports | SFEBES2009

Forensic endocrinology: a case report of factitious hypoglycaemia

Cheah Yee Seun , Etok Atim , Gough Andrew , Kane Pauline , Aylwin Simon , Schulte Klaus-Martin , Gilbert Jackie

A 51-year-old female presented with a 9 month history of symptoms suggestive of hypoglycaemia and associated episodes of unconsciousness, which were prevented by frequent food intake but with subsequent weight gain. She reported a history of lactose-induced anaphylaxis and the use of lactose-free subcutaneous prednisolone since sustaining a traumatic cardiac injury in 1987.Two supervised prolonged fasts demonstrated hypoglycaemia with elevated insulin le...

ea0021p409 | Thyroid | SFEBES2009

Screening of six novel candidate genes for association with Graves' disease

Tisdall Ruth , Simmonds Matthew , Newby Paul , Franklyn Jayne , Gough Stephen , Brand Oliver

Genome wide association screening (GWAS) has proved invaluable in determining otherwise undetected genetic effects for several common endocrine diseases. The largest GWAS performed in Graves’ disease (GD), to date, has not only confirmed association of several known gene regions, including the HLA region, TSHR and FCRL3, but has also identified several other possible regions of association with GD. As GD shares several susceptibility loci with other endocrin...

ea0019p373 | Thyroid | SFEBES2009

Further evidence for a key role of FcGR2a in autoimmunity

Yesmin K , Hargreaves C , Newby P , Brand O , Heward J , Franklyn J , Gough S , Simmonds M

Autoimmune diseases (AIDs) have been shown to share a series of genetic susceptibility loci, including the HLA class II region, CTLA-4 and PTPN22, indicating the sharing of key pathways between diseases. Recently, the rs1801274 single nucleotide polymorphism (SNP) within the Fc gamma receptor 2a gene (FcGR2a) has been shown to be associated with several common AIDs including type 1 diabetes, rheumatoid arthritis and coeliac disease. FcGR2a is an immune mod...

ea0019p375 | Thyroid | SFEBES2009

Association of another member of the FCRL family with Graves' disease: further evidence for disrupted B cell signalling in disease pathogenesis

Simmonds M J , Newby P R , Franklyn J A , Gough S C L

Identifying the pathogenic pathways involved in complex diseases such as Graves’ disease (GD) has proved challenging. Although several genetic risk factors, including the HLA class II region, CTLA4, PTPN22 and CD25, encode molecules playing key roles in antigen presentation and controlling T cell recognition/signalling, the identification of novel susceptibility loci has the potential to provide further insights into disease pathogenesis. Recently gen...